CN Patent

CN118401497A — 雷芬那辛的结晶型丙酮溶剂化物

Assigned to Medichem SA · Expires 2024-07-26 · 2y expired

What this patent protects

本发明涉及雷芬那辛的新型结晶型丙酮溶剂化物及其制备方法。本发明还涉及其用于制备I型雷芬那辛的用途。

USPTO Abstract

本发明涉及雷芬那辛的新型结晶型丙酮溶剂化物及其制备方法。本发明还涉及其用于制备I型雷芬那辛的用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN118401497A
Jurisdiction
CN
Classification
—
Expires
2024-07-26
Drug substance claim
No
Drug product claim
No
Assignee
Medichem SA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.